Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% dextrose-water vs triamcinolone intracarpal injection for carpal tunnel syndrome
TCTR20221020001Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone, dextrose in carpal tunnel syndrome (CTS), sponsored by Thammasat University. Started Nov 2022; status: completed.
02
Drugs
triamcinolonedextrose
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on TCTR20221020001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221020001.